RESEARCH USE ONLYA research peptide studied for its potential role in recovery and tissue-repair pathways.
RESEARCH USE ONLY
Retatrutide — 10 MG
COMING SOON
An investigational triple-receptor agonist being studied in obesity and metabolic-health research.
RESEARCH USE ONLY
This product is presented for research use only and is not for human consumption.
READ PRODUCT DISCLAIMERRESEARCH USE ONLYNOT FOR HUMAN CONSUMPTION10 MG
PRODUCT DETAILS
Retatrutide is an investigational peptide that activates GLP-1, GIP, and glucagon receptors involved in appetite, blood-sugar, and energy-metabolism pathways. Ongoing clinical research is evaluating effects on body weight, food intake, metabolic markers, blood-sugar regulation, and obesity-related conditions. Retatrutide is not FDA approved and has not been found safe and effective for any condition.
SPECIFICATIONS
- Retatrutide investigational research peptide
- 10 MG lyophilized presentation
- Research use only — not for human consumption
CARE / STORAGE
Store refrigerated at 2–8°C (36–46°F) and protect from light. Final handling instructions must match the verified product label.
SHIPPING & RETURNS
This research-product preview does not enable purchasing or shipping.
COMPLETE THE SYSTEM
SHOP ALL →BUILT TOGETHER.
RESEARCH USE ONLY
RESEARCH USE ONLYA copper-binding peptide studied in tissue-repair, skin-remodeling, and cellular-regeneration pathways.
RESEARCH USE ONLYA growth hormone-releasing hormone analogue studied in GH, IGF-1, visceral-fat, and body-composition research.
THE RESEARCH STANDARD
RESEARCH USE ONLY.
RETATRUTIDE — 10 MG · NOT FOR HUMAN CONSUMPTION